Insights |
By Topic
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Blue Chip Stocks
Growth Stocks
CSL at All-Time Highs: $320 Fair Value or Defensive Premium?
CSL (ASX:CSL) is trading near record highs around $290. With plasma recovery complete and Vifor integration ahead of schedule, is CSL’s 35x valuation justified—or are investors paying a defensive premium?
